Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines
Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical and Biotech Market (3rd Edition), 2023-2035” report to its list of offerings.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution of the market for modular facilities over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
- An executive summary of the key insights captured during our research
- A brief introduction to important concepts related to modular facilities, featuring information on different types of modular constructs, primary applications of modular facilities in the pharmaceutical and biotechnology domain
- A detailed overview of the current market landscape of players engaged in the development of modular facilities, along with information on their year of establishment, company size and location of headquarters, type of industry served, geographical coverage, GMP compliance, type of modular construction, type of material used, and quality certification(s) obtained
- A detailed overview of the current market landscape modular cleanroom providers, based on their year of establishment, company size, location of headquarters, type of industry served, type of modular cleanroom offered, type of cleanroom component offered and quality certification(s) obtained
- An insightful competitiveness analysis of players involved in the modular facilities manufacturing in the healthcare domain
- Elaborate profiles of various prominent players that are currently engaged in the modular facilities domain.
- An insightful analysis of the partnerships inked between various stakeholders, during the period 2012-2022
- A detailed case study on modular projects undertaken across key geographical regions, featuring information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility
- A detailed overview of facility construction trends in the pharmaceutical industry for the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with information on their number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters
- An insightful framework that enables a thorough examination of the cost and time related benefits offered by the use of different modular approaches
- A detailed market forecast analysis, highlighting the likely growth of the modular facilities market, for the period 2023-2035
- Size of Facility
- Small Plants
- Mid-sized Plants
- Large Plants
- Very Large Plants
- Type of Industry Served
- Pharmaceutical
- Biotechnology
- Type of Modular Construct
- Hybrid Skid Modular Constructs
- Plug-and-Play Modular Constructs
- Skid-Mounted Modular Constructs
- Truckable Modular Constructs
- Others Modular Constructs
- Type of Construction Component
- Process Equipment
- Base Building
- Mechanical, Electrical and Plumbing System
- Process Commodities
- Other Construction Components
- Type of Facility
- Manufacturing
- Aseptic Filling
- Research and Development
- Others
- Scale of Operation
- Clinical
- Commercial
- Type of Product
- Cell and Gene Therapies
- Vaccines
- Biosimilars
- Monoclonal Antibodies
- Advanced Pharmaceuticals
- Sterile Products
- Viral Vectors
- Other Products
- Type of Expansion
- New Facilities
- Facility Expansions
- Planned Expansions
- Type of Modular Construction
- Relocatable
- Permanent
- Type of Material
- Steel
- Wood
- Concrete
- Key Geographical Regions
- North America
- Europe
- Asia
- Middle East and North Africa (MENA)
- Rest of the world
Key companies covered in the report
- Cytiva
- G-CON Manufacturing
- Germfree
- IPM Technologies
- KeyPlants
- ModuleCo Pharma
- NNE
- Pharmadule
To view more details on this report, click on the link
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
| T-cell Immunotherapies: The Future of Modern Cancer Treatments |
| Monkeypox: Disease Overview, Transmission and Diagnosis |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415